Benzodiazepine use among young attendees of an Irish substance treatment center

Show simple item record Murphy, Kevin D. Byrne, Stephen McCarthy, Suzanne Lambert, Sharon Sahm, Laura J. 2018-05-23T11:22:47Z 2018-05-23T11:22:47Z 2014-05
dc.identifier.citation Murphy, K. D., Byrne, S., McCarthy, S., Lambert, S. and Sahm, L. J. (2014) 'Benzodiazepine Use Among Young Attendees of an Irish Substance Treatment Center', Journal of Addiction Medicine, 8(3), pp. 199-204. doi: 10.1097/ADM.0000000000000025 en
dc.identifier.volume 8 en
dc.identifier.startpage 199 en
dc.identifier.endpage 204 en
dc.identifier.issn 1932-0620
dc.identifier.doi 10.1097/ADM.0000000000000025
dc.description.abstract Objective: To describe the demographic characteristics of those service users attending Matt Talbot Services, and their current and past substance use, and to explore the use of benzodiazepines among this group. Method: There were 198 service users who attended a substance misuse treatment center in Cork, Ireland, between January 2005 and August 2011. Results: Benzodiazepines had ever been used by 51.0%, and of these, 55.8% were regular benzodiazepine users. The mean age of first use was 14.9 ± 1.4 years. Regular users of benzodiazepines were regular users of significantly more substances (3, interquartile range [IQR] = 2-3) when compared with nonregular benzodiazepine users (1, IQR = 1-2). Regular benzodiazepine users showed more behavioral signs (12, IQR = 10-14) than nonregular users (9, IQR = 7-12). Physical signs were significantly different between regular (8, IQR = 6-11) and nonregular (5, IQR = 3-10) users. Conclusions: The effects of benzodiazepine misuse affect the individual, their family, and society as a whole through hospitalization, substance treatment, and crime. Identifying regular benzodiazepine users can help reduce the burden of benzodiazepines. en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher Lippincott, Williams & Wilkins en
dc.rights © 2014 American Society of Addiction Medicine. This is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Addiction Medicine, doi: 10.1097/ADM.0000000000000025 en
dc.subject Benzodiazepines en
dc.subject Ireland en
dc.subject Treatment center en
dc.subject Young people en
dc.subject Metaanalysis en
dc.subject Withdrawal en
dc.subject Dementia en
dc.subject Diazepam en
dc.subject Risk en
dc.title Benzodiazepine use among young attendees of an Irish substance treatment center en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Kevin Murphy, School Of Pharmacy, University College Cork, Cork, Ireland. +353-21-490-3000 Email: en
dc.internal.availability Full text available en 2018-05-23T08:57:16Z
dc.description.version Accepted Version en
dc.internal.rssid 271354954
dc.internal.wokid 000337375800008
dc.description.status Peer reviewed en
dc.identifier.journaltitle Journal Of Addiction Medicine en
dc.internal.copyrightchecked Yes en
dc.internal.licenseacceptance Yes en
dc.internal.IRISemailaddress en
dc.internal.IRISemailaddress en
dc.internal.IRISemailaddress en

Files in this item

This item appears in the following Collection(s)

Show simple item record

This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement